Related Experiment Videos

[Advances treatment of osteoporosis: new molecules, new strategies]

Philippe Orcel1

  • 1Hôpital Lariboisière, 41 bid de la Chapelle, 75475 Paris cedex 10. philippe.orcel@lrb.aphp.fr

Bulletin De L'Academie Nationale De Medecine
|November 4, 2011
PubMed

Insights

New osteoporosis treatments targeting bone cell biology are emerging. These innovative therapies aim to prevent fractures by inhibiting bone resorption or stimulating bone formation, offering new hope for patients.

Area of Science:

  • Bone cell biology
  • Osteoclast and osteoblast targeted therapies

Context:

  • Osteoporosis is a chronic, disabling disease requiring new fracture prevention strategies.
  • Existing treatments are effective, but limitations necessitate novel therapeutic approaches.

Purpose:

  • To explore recent advances in bone cell biology for novel osteoporosis treatments.
  • To identify specific molecular targets for inhibiting bone resorption and stimulating bone formation.

Summary:

  • Recent research highlights targets for osteoporosis treatment, including anti-RANK ligand antibodies and cathepsin K inhibitors to reduce bone resorption by osteoclasts.
  • Stimulating bone formation by osteoblasts is also a key focus, with anti-sclerostin antibodies representing a promising avenue.
  • Anti-RANK ligand antibodies are expected to be available soon, marking a significant advancement.

Impact:

  • These targeted biotherapies represent a significant advancement in managing osteoporosis.
  • Future treatments will expand the options for preventing fractures in osteoporosis patients.
  • Osteoporosis is increasingly becoming a disorder amenable to targeted biotherapies.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...